Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 10.90
-0.04 (-0.37%)
Nov 12, 2026, 9:35 AM CET
Genfit Market Cap
Genfit has a market cap or net worth of €545.34 million as of November 11, 2026. It is the 13,183rd most valuable company in the world and the 181st biggest in France. Its market cap has increased by 198.41% in one year.
Market Cap
545.34M
Enterprise Value
610.80M
Revenue
59.49M
Global Rank
Country Rank
#181 France
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 545.34M, an increase of 273.35%. That is a compound annual growth rate of 6.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 545.34M | 108.01% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.47B |
| MedinCell | 1.07B |
| Inventiva | 793.90M |
| DBV Technologies | 630.29M |
| Valneva SE | 492.95M |
| Valerio Therapeutics Société anonyme | 237.24M |
| Transgene | 206.78M |
| Innate Pharma | 123.68M |